Methods To make a statistic analysis of the Oral Hypoglycemic agents used in my hospital during the period 2000~ 2003 with the sum of money, DDDs and daily cost.

An experimental diabetic model was induced by vein injection of alloxan monohydrate ( 100 mg/ kg). We observed the effects of LBP-D, hypoglycemic agents alone or in combination, on blood glucose and the functions of cellular immunity in alloxan-induced diabetes mice.

利用四氧嘧啶静脉注射（100mg/kg）诱导的糖尿病小鼠模型，观察LBP-D单独及与降糖药联合应用对小鼠血糖和细胞免疫功能的影响。

Dipeptidyl peptidase ⅳ inhibitor ( dipeptidyl peptidase-4 inhibitor, DPP-ⅳ inhibitors) is currently developing a new, efficient one of hypoglycemic agents.

二肽基肽酶Ⅳ抑制剂（？）（dipeptidyl peptidase-4inhibitor，DPP-Ⅳ抑制剂）就是目前开发的一种新的、有效的降糖药之一。

The results provided theoretic basis for the molecular biochemical mechanism of POV lowering hyperglycemia, and provided experimental base for exploring a new lowering hyperglycemia drug.

此结果为POV降低高血糖的分子生化机理提供理论依据，亦为探讨治疗糖尿病新的降糖药提供实验基础。

Conclusions The effect of treating hyperglycemia on insulin pump therapy in newly diagnosed T2DM is better than that in T2DM with failure to oral antidiabetic therapy.

结论初诊的T2DM患者可能较口服降糖药效果差的T2DM患者对胰岛素泵降糖效果更满意。

Methods Forty type 2 diabetes patients which could not control the blood glucose successfully with drugs were divided into two groups randomly: glargine group ( 20 cases) and mixed insulin group ( 20 cases).

方法40例用口服降糖药血糖控制不良的2型糖尿病患者随机分为甘精胰岛素组（简称甘精组）和预混胰岛素组（诺和灵30R，简称预混组），每组各20例。

This is true of many other diabetes pills, too.

其他许多降糖药也有类似情况。

Thirty-four NIDDM patients were given 4-month dietary control and/ or oral hypoglycemic agent treatment and it showed that the GFR, kidney volume and UAE were partially reduced in 12 patients with improved metabolic control;

34例NIDDM患者经饮食控制和／或口服降糖药治疗4个月后进行了复查，结果显示：12例代谢改善者的GFR、肾脏体积和UAE有不同程度的恢复；

Cost-effectiveness analysis of drugs in treatment of type 2 diabetes mellitus

2型糖尿病患者口服降糖药的成本效果分析

⑵ With the increase of course, inpatients respectively with therapy of OHA or insulin significantly decreased and increased, but the overall ratio of insulin was low.

⑵老年DM住院患者随病程延长口服降糖药治疗者明显减少，胰岛素应用比例逐渐增加，但总体胰岛素使用率较低；

The Retrospectively Dynamic Analysis of Hypoglycemic Agents in 2006-2008 at Our Hospital

我院2006&2008年降糖药回顾性动态分析

[ Methods] Included were 31 cases of elderly diabetes mellitus diagnosed by criteria of WHO. All patients had lower effect on oral hypoglycemia agent, were added to given Novolin N injection at bedtime.

方法31例符合WHO诊断标准口服降糖药治疗血糖控制不满意的老年糖尿病患者，联合睡前注射诺和灵N。

The two antihypertensive drugs are characteristics of specific receptor, medication safety, well-tolerated, significant antihypertensive effect, lower side effect.5-carboxylic acid Losartan ( EXP-3174) is the active metabolite of Losartan.

这两种降糖药具有受体作用的专一性，用药安全，耐受性良好，抗高血压作用显著，副作用小的特点。5-羧酸洛沙坦（EXP-3174）是洛沙坦的活性代谢产物。

Conclusion Bedtime basal insulin added to oral therapy can safely achieve HbAlc less than 7% in majority of patients with type 2 diabetes with HbAlc> 7.5% on oral agents alone.

结论口服降糖药治疗且血糖控制不良的2型糖尿病患者，睡前加用基础胰岛素，可使绝大多数患者血糖获得理想控制（HbAlc≤7%）。

[ Conclusion] Recombinant human insulin injection Novolin N and oral hypoglycemia agent combination therapy on elderly diabetes mellitus is safety and effective.

结论用重组人胰岛素诺和灵N联合口服降糖药治疗老年糖尿病是安全有效的。

Sodium-glucose co-transporter is currently developing a new, efficient one of hypoglycemic agents.

钠-葡萄糖共转运体抑制剂（sodium-glucose co-transporter，SGLT-2抑制剂）是目前开发的一种新的、有效的降糖药方向之一。

Methods 80 cases were randomly divided into acupuncture treatment group ( A), exercise therapy group ( B), acupuncture plus exercise therapy group ( C), and control group ( D) treated with rational diet and oral administration of hypoglycemia agents.

方法：80例患者随机分为针刺治疗组（A）、运动疗法组（B）、针刺结合运动疗法组（C）、和单纯进行合理饮食及口服降糖药治疗对照组（D）。

Clinical observation of recombinant human insulin injection novolin N and oral hypoglycemia agent combination therapy on elderly diabetes mellitus

诺和灵N联合口服降糖药治疗老年糖尿病的临床观察

Result: The DDDs of oral antidiabetic agents rised gradually from 2001 to 2003.The front of DDDs were among Gliclazide, Tolbutamide and Metformin.

结果：2001～2003年我院口服降糖药的DDDs呈现逐年上升，其中格列齐特、甲苯磺丁脲、二甲双胍位居前列；

Survey the actuality of using oral hypoglycemic drug in our hospital

我院口服降糖药使用现状调查与分析

The safety indicators, liver and kidney function, ECG, blood, urine, stool routine examination, with no abnormal changes, and no complication occurred. Conclusions: 1.

两组患者安全性指标肝肾功能、心电图、血、尿、大便常规检查均无异常变化，无并发症发生。